ArticleCancer management and research2024

Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway.

Seunghee Bae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.